Showing results (1-10 of 219) with videos related to
Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1995
High molecular weight DNA fragmentation: a critical event in nucleoside analogue-induced apoptosis in leukemia cellsP Huang, L E Robertson, S Wright, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacologyV Gandhi, L E Robertson, M J Keating, et al.Blood Reviews|September 1, 1994
The role of fludarabine in hematological malignanciesS J Wright, L E Robertson, S O'Brien, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Cellular pharmacodynamics and plasma pharmacokinetics of parenterally infused hydroxyurea during a phase I clinical trial in chronic myelogenous leukemiaV Gandhi, W Plunkett, H Kantarjian, et al.Leukemia|March 1, 1996
Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcomeL E Robertson, W Plunkett, K McConnell, et al.Drugs|January 1, 1994
Clinical experience with fludarabine in leukaemiaM J Keating, E Estey, S O'Brien, et al.Blood|January 1, 1993
Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenineL E Robertson, S Chubb, R E Meyn, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabineL E Robertson, A W Denny, Y O Huh, et al.Seminars in Oncology|October 1, 1993
Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapiesW Plunkett, V Gandhi, P Huang, et al.Leukemia & Lymphoma|May 1, 1993
High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysisL E Robertson, R Hall, M J Keating, et al.Pageof 22